Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Sell
35,499
-188,587
-84% -$18.2M ﹤0.01% 2702
2026
Q1
$21.7M Sell
224,086
-80,855
-27% -$9.37M 0.01% 1098
2025
Q4
$34.1M Buy
304,941
+137,897
+83% +$15.8M 0.02% 917
2025
Q3
$18.7M Buy
167,044
+86,843
+108% +$10.3M 0.01% 1221
2025
Q2
$9.67M Buy
80,201
+76,510
+2,073% +$9.25M 0.01% 1520
2025
Q1
$430K Sell
3,691
-1,031
-22% -$126K ﹤0.01% 3580
2024
Q4
$566K Sell
4,722
-8,600
-65% -$1.04M ﹤0.01% 3537
2024
Q3
$1.42M Sell
13,322
-34,926
-72% -$3.46M ﹤0.01% 2989
2024
Q2
$4.56M Buy
48,248
+25,217
+109% +$2.62M ﹤0.01% 1927
2024
Q1
$2.55M Sell
23,031
-56,405
-71% -$5.27M ﹤0.01% 2442
2023
Q4
$6.88M Buy
79,436
+57,166
+257% +$4.33M 0.01% 1649
2023
Q3
$1.56M Buy
22,270
+6,975
+46% +$485K ﹤0.01% 2772
2023
Q2
$1.02M Sell
15,295
-2,277
-13% -$138K ﹤0.01% 3077
2023
Q1
$1.04M Sell
17,572
-2,854
-14% -$163K ﹤0.01% 3134
2022
Q4
$958K Sell
20,426
-1,655
-7% -$69.3K ﹤0.01% 3475
2022
Q3
$737K Sell
22,081
-3,814
-15% -$156K ﹤0.01% 3803
2022
Q2
$1.13M Buy
+25,895
New +$1.25M ﹤0.01% 3550

Other funds holding ESAB

David Shaw's ESAB Position: Q2 2026 in Review

David Shaw reduced its ESAB (ESAB) stake by 84% in Q2 2026, selling an estimated $18.2M and leaving 35,499 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

David Shaw first reported a position in ESAB in Q2 2022 and has held it in 17 quarters since. The position peaked at $34.1M in Q4 2025. 345 funds tracked by Wall St. Rank hold ESAB as of Q2 2026.

  • David Shaw held 35,499 shares of ESAB worth $3.5M as of Q2 2026.
  • David Shaw sold 188,587 ESAB shares in Q2 2026, an estimated $18.2M.
  • ESAB made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2702 holding.
  • David Shaw first reported a position in ESAB in Q2 2022 and has held it in 17 quarters since.
  • David Shaw's ESAB position peaked at $34.1M in Q4 2025.
  • 345 funds tracked by Wall St. Rank held ESAB as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.